Literature DB >> 2901412

Transport-deficient mutations in the low density lipoprotein receptor. Alterations in the cysteine-rich and cysteine-poor regions of the protein block intracellular transport.

V Esser1, D W Russell.   

Abstract

Certain individuals with familial hypercholesterolemia (FH) produce mutant forms of the low density lipoprotein (LDL) receptor that fail to move from the endoplasmic reticulum to the Golgi complex. Here, we describe the cloning and expression of one such mutant allele, FH 429. The mutation causes a substitution of a Val for a Gly at residue 544. When recreated in an expressible cDNA, this substitution gives rise to an LDL receptor that is not transported to the cell surface and is rapidly degraded. Three previously mapped transport-deficient alleles of the LDL receptor were traced to the cysteine-rich repeats of the protein, suggesting that the generation of non-disulfide-bonded (free) cysteines might cause the block in transport. The FH 429 mutation is not located in a cysteine-rich region, however. We have attempted to test the role of cysteine by expressing mutant cDNAs that encode proteins blocked in transport and predicted to contain free cysteines. The results suggest that free cysteines are not obligatory for the blocked intracellular movement of mutant LDL receptors.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2901412

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  Lucky, times ten: A career in Texas science.

Authors:  David W Russell
Journal:  J Biol Chem       Date:  2018-12-07       Impact factor: 5.157

2.  Endoplasmic reticulum localization of the low density lipoprotein receptor mediates presecretory degradation of apolipoprotein B.

Authors:  Donald L Gillian-Daniel; Paul W Bates; Angie Tebon; Alan D Attie
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

3.  Common low-density lipoprotein receptor mutations in the French Canadian population.

Authors:  E Leitersdorf; E J Tobin; J Davignon; H H Hobbs
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

4.  Mutations in the low-density-lipoprotein receptor gene in German patients with familial hypercholesterolaemia.

Authors:  N Weiss; G Binder; C Keller
Journal:  J Inherit Metab Dis       Date:  2000-12       Impact factor: 4.982

5.  Mutating a conserved cysteine in GPIHBP1 reduces amounts of GPIHBP1 in capillaries and abolishes LPL binding.

Authors:  Christopher M Allan; Cris J Jung; Mikael Larsson; Patrick J Heizer; Yiping Tu; Norma P Sandoval; Tiffany Ly P Dang; Rachel S Jung; Anne P Beigneux; Pieter J de Jong; Loren G Fong; Stephen G Young
Journal:  J Lipid Res       Date:  2017-05-05       Impact factor: 5.922

Review 6.  The ApoE receptors Vldlr and Apoer2 in central nervous system function and disease.

Authors:  Courtney Lane-Donovan; Joachim Herz
Journal:  J Lipid Res       Date:  2017-03-14       Impact factor: 5.922

7.  An exon 4 mutation identified in the majority of South African familial hypercholesterolaemics.

Authors:  M J Kotze; L Warnich; E Langenhoven; L du Plessis; A E Retief
Journal:  J Med Genet       Date:  1990-05       Impact factor: 6.318

8.  Formation of reversible disulfide bonds with the protein matrix of the endoplasmic reticulum correlates with the retention of unassembled Ig light chains.

Authors:  P Reddy; A Sparvoli; C Fagioli; G Fassina; R Sitia
Journal:  EMBO J       Date:  1996-05-01       Impact factor: 11.598

9.  Identification of a point mutation in growth factor repeat C of the low density lipoprotein-receptor gene in a patient with homozygous familial hypercholesterolemia that affects ligand binding and intracellular movement of receptors.

Authors:  A K Soutar; B L Knight; D D Patel
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

10.  Deletion of two growth-factor repeats from the low-density-lipoprotein receptor accelerates its degradation.

Authors:  D R van der Westhuyzen; M L Stein; H E Henderson; A D Marais; A M Fourie; G A Coetzee
Journal:  Biochem J       Date:  1991-08-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.